Biopharm Co. To Repay Lender $4M In Ch. 11 Collateral Row
Pressed by a venture capital lender and Delaware bankruptcy court, cancer drug developer BIND Therapeutics Inc. agreed Wednesday to deliver $4 million to the lender by Friday in exchange for use...To view the full article, register now.
Already a subscriber? Click here to view full article